Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01837069 · ClinicalTrials.gov registry record · Phase 4
Risk Factor Control Before Orthopedic Surgery
A Phase 4 study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 198
- Enrollment target
NCT01837069 is a Phase 4 study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 198 participants.
The verdict
NCT01837069, a Phase 4 study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 198 participants
- Enrollment target
Study Summary
This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.
Interventions
- DRUG Atorvastatin
- DRUG Metoprolol
- DRUG Lisinopril
- BEHAVIORAL Lifestyle counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2014-02 |
| Est. Completion | 2018-04-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01837069
The ClinicalTrials.gov registry entry for NCT01837069 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Atorvastatin is the first listed.
NCT01837069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01837069 about?
NCT01837069 is a clinical study titled "Risk Factor Control Before Orthopedic Surgery". This trial is designed to determine the best preoperative management strategy for patients undergoing orthopedic surgery.
What is the current status of trial NCT01837069?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 198 participants. The study started on 2014-02. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT01837069?
The interventions under investigation include: Atorvastatin (DRUG), Metoprolol (DRUG), Lisinopril (DRUG), Lifestyle counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01837069?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.